Scholar Rock Holding (FRA:2QK) Moat Score: 5/10 (As of Jul. 08, 2026)


FRA:2QK Scholar Rock Holding Corp FRA:2QK
30 GF Score
Price €48.14
! 5 Warning Signs
View Full Analysis

What is Scholar Rock Holding Moat Score?

Scholar Rock Holding FRA:2QK +0.96% 30 Moat Score is 5 as of Jul. 08, 2026. GuruFocus rates FRA:2QK with a GF Score™ of 30/100. The stock has 5 warning signs investors should review. Among 1,393 Biotechnology companies, Scholar Rock Holding ranks better than 96.7% on this metric.

Scholar Rock Holding has the Moat Score of 5, which implies that the company might have Narrow Moat - Solid narrow moat.

Scholar Rock Holding has Narrow Moat: Scholar Rock has a solid narrow moat based on its innovative R&D capabilities and proprietary technology in the biopharmaceutical sector. While it holds valuable patents, the competitive nature of the industry and regulatory hurdles limit its moat to narrow.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Scholar Rock Holding might have Narrow Moat - Solid narrow moat.

Scholar Rock Holding  (FRA:2QK) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Scholar Rock Holding Moat Score Related Terms

FRA:2QK vs COGT, CGON, PTCT: Moat Score Comparison

For the Biotechnology subindustry, Scholar Rock Holding's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scholar Rock Holding Moat Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scholar Rock Holding's Moat Score distribution charts can be found below:

* The bar in red indicates where Scholar Rock Holding's Moat Score falls into.


FRA:2QK
30GF Score
Scholar Rock Holding Corp FRA:2QK
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 5 mean?
Scholar Rock Holding (FRA:2QK) has a Moat Score of 5 as of Jul. 08, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Scholar Rock Holding ranks #46 out of 1393 companies in the Biotechnology industry, placing it in the top 3.3%.
Is Scholar Rock Holding's Moat Score too high?
Scholar Rock Holding's current Moat Score is 5. The Biotechnology industry median Moat Score is 2.00. Scholar Rock Holding's value of 5 is 150% above this industry median. Based on the distribution chart, Scholar Rock Holding ranks #46 out of 1393 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Scholar Rock Holding has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Scholar Rock Holding's Moat Score compare to COGT and CGON?
According to the Biotechnology industry distribution chart, Scholar Rock Holding ranks #46 out of 1393 companies for Moat Score. This places Scholar Rock Holding in the top 3% of its industry — outperforming the majority of peers. The industry median Moat Score is 2.00. Scholar Rock Holding's value of 5 is 150% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Biotechnology company?
The median Moat Score among Biotechnology companies is 2.00, based on 1,393 companies in the industry. Companies in the top quartile (top 25%) have a Moat Score significantly above this median, while those in the bottom quartile fall well below. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Scholar Rock Holding's current Moat Score of 5 is 150% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. For the Biotechnology industry, the median Moat Score is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Scholar Rock Holding's current Moat Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scholar Rock Holding stock overvalued right now?
Scholar Rock Holding (FRA:2QK) has a current Moat Score of 5. The current Moat Score is 5 and 150% above the Biotechnology industry median of 2.00. Scholar Rock Holding's overall GF Score™ is 30/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Scholar Rock Holding (FRA:2QK), the current Moat Score is 5 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scholar Rock Holding Business Description

Other Exchanges SRRK:USA2QK:Germany
Address 301 Binney Street, 3rd Floor, Cambridge, MA, USA, 02142
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
30GF Score

Get the complete analysis for FRA:2QK

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€48.14
Price